Angiodynamics, Inc. (NASDAQ: ANGO) reported Q3 EPS of $0.09, $0.01 better than the analyst estimate of $0.08. Revenue for the quarter came in at $51.6 million versus the consensus estimate of $51.34 million.

Angiodynamics, Inc. sees FY2012 EPS of $0.42-$0.44, versus the consensus of $0.39. Angiodynamics, Inc. sees FY2012 revenue of $216.2-$218.2 million, versus the consensus of $216.5 million.

Angiodynamics, Inc. sees Q4 2012 EPS of $0.09-$0.11, versus the consensus of $0.10. Angiodynamics, Inc. sees Q4 2012 revenue of $52.1-$54.1 million, versus the consensus of $53.08 million.

For earnings history and earnings-related data on Angiodynamics, Inc. (ANGO) click here.

Earnings Guidance